NAME : Mr. SIDDHARTHA Lab No.
: 00012004230002
Barcode No. : 10071738 Age / Sex : 28 Y 0 M 0 D /Male
Referred By : Dr. SURJEET KUMAR CentreCode : TPC DRR
Pat. Address : Sample Recieved : 23/Apr/2020 03:49PM
Approval Date : 23/Apr/2020 04:41PM Sample Collection : 23/Apr/2020 03:49PM
Department of ELISA.
Test Result Units Biological Reference Interval
HBSAG BY CARD (QUALITATIVE)
HBsAg (RAPID) NEGATIVE NON REACTIVE
Comment
This assay detects the first serological marker of Hepatitis B as early as 4-16 weeks after exposure. It persists during acute illness and
disappears 12-20 weeks after onset of symptoms. The titers rise rapidly during the period of viral replication and is frequently associated
with infectivity. Persistence of HBsAg for more than 6 months indicates development of carrier state or chronic liver disease.
The enzyme immunoassay method for the detection of Hepatitis B surface antigen is a highly sensitive screening test and can therefore
yield false positive results. The proportion of false reactives will depend on the sensitivity and specificity of the test kit. Hence it is
recommended that a positive result of HBsAg must be be confirmed using a different enzyme immunoassay kit or by using a confirmatory
assay based on neutralisation with human anti hepatitis B surface antibody.
Based upon clinical history it may become necessary to test for presence of other markers of hepatitis B virus infection.
NOTE It is a screening test result may be confirmed by another methods if indicated .
To be correlated clinically.
Sample Collected On : 23/Apr/2020 03:49PM Page 1 of 9
Authenticated On : 23/Apr/2020 04:40PM
TYPHIDOT IGG/IGM
Typhidot IgG* NEGATIVE
Typhidot IgM* NEGATIVE
Summary
Typhoid fever is caused by gram negative bacteria Salmonella typhi transmitted through ingestion of contaminated food or
water. Typhoid fever is charecterized by prolonged fever, headache, bowel dysfunction, malaise and in early stage cough is also
common. In chronic cases the bacteria is detected in the stool even after an year of the onset of disease. Typhoid is one of the
major cause of morbidity and mortality worldwide. Immuno compromised patients and patients with Helicobacter pylori
infection are at a high risk. Diagnosis of typhoid fever at an early stage is of great importance not only for etiological reasons but
to identify potential carriers and prevent acute typhoid fever outbreaks. Detectable levels of antibodies appear after the onset of
disease. During the initial acute phase in the second week of infection IgM antibodies are detected and persists for four months.
IgG antibodies are detected thereafter and remain in the blood for about two years. The detection of IgM antibodies reveals
initial acute phase of infection. while the detection of specific IgG suggests a potential carrier and highrate of typhoid
transmission.
Interpretation
Results should be correlated clinically.
Borderline result requires repeat sample after 3-4 days, if clinical findings are suggestive.
IgM positive only : Acute typhoid fever
IgM & IgG positive : Acute typhoid fever (in the middle stage of infection)
IgG positive : Previous infection, relapse or re-infection, interpretation with clinical.
Sample Type S e r u m
Methodology
Two site sandwich immunoassaybased on the principal of immunochromatography on a membrane.
Reference
Reagent Kit insert.
Remarks
Please correlate results clinically.
Sample Collected On : 23/Apr/2020 03:49PM Page 2 of 9
Authenticated On : 23/Apr/2020 04:40PM
Limitations
1. A negative result for an individual subject indicates abscence of detectable anti-S. Typhi antibodies. However, a negative
test result does not preclude the possibility of exposure to S.typhi. A negative result cn occur if the detection limit of the
assay, or the antibodies that are detectedare not present during the stage of disease in which the sample is collected.
2. As with all other diagnostic tests TYPHOID IgM/IgG should be interpreted by the physician in conjuction with other
diagnostic procedures and clinical findings.
Disclaimer:
1. This report is not for medico-legal purposes.
2. Rikh Path Lab Pvt. Ltd. cannot be held responsible for Sample Labelling Errors done at the Collection
Centre/Physician’s office besides done by authorised personnel from Rikh Path Lab Pvt. Ltd.
Sample Collected On : 23/Apr/2020 03:49PM Page 3 of 9
Authenticated On : 23/Apr/2020 04:40PM
NAME : Mr. SIDDHARTHA Lab No. : 00012004230002
Barcode No. : 10071738 Age / Sex : 28 Y 0 M 0 D /Male
Referred By : Dr. SURJEET KUMAR CentreCode : TPC DRR
Pat. Address : Sample Recieved : 23/Apr/2020 03:49PM
Approval Date : 23/Apr/2020 04:41PM Sample Collection : 23/Apr/2020 03:49PM
Department of ELISA.
Test Result Units Biological Reference Interval
HCV BY CARD (QUALITATIVE)
HCV RAPID NEGATIVE undefined NON REACTIVE
Brief:
Hepatitis C Virus (HCV) is a single-stranded RNA virus . It is know to be the major cause of parenterally transmitted non-A,
non-B hepatitis. In the past, diagnosis was made by exclusion of all other known causes of Hepatitis. Antibody to HCV is found in
over 80% of patients with well documented non-A, non-B hepatitis. The worldwide prevalence of HCV is 80% in intravenous-
drug users and upto 0.2 to 2% in blood donorsin a large percentage of HCV cases, transmission is by transfusion and other
parenteral means such as sharing of needles, occupational exposure to blood and hemodylasis. HCV estabiishes a chronic
infection in 50%-80% of cases. Chronic infection remains asymptomatic even in the presence of liver damage discernible on
biopsy Chronic HCV is characterized by fluctuating alanine aminotransferase levels and recognizable changes in liver
histology. Chronic infection can lead to cirrhosis and hepatocellular carcinoma.
Sample Type: S e r u m / P l a s m a
Methodology: R a p i d I m m u n o c h r o m a t o g r a p h y A s s a y .
Reference:
Test Kit Insert.
Disclaimer:
1. This report is not for medico-legal purposes. Please consult your physician to correlate clinically.
2. Rikh Path Lab Pvt. Ltd. cannot be held responsible for Sample Labelling Errors done at the Collection
Centre/Physician’s office besides done by authorised personnel from Rikh Path Lab Pvt. Ltd.
*** End of Report ***
Sample Collected On : 23/Apr/2020 03:49PM Page 4 of 9
Authenticated On : 23/Apr/2020 04:40PM
Disclaimer: This report is not for medico-legal purposes. Please consult your physician to correlate clinically.
NABL ACCREDITED & ISO 9001:2015 CERTIFIED LABORATORY
Sample Collected On : 23/Apr/2020 03:49PM Page 5 of 9
Authenticated On : 23/Apr/2020 04:40PM
NAME : Mr. SIDDHARTHA Lab No. : 00012004230002
Barcode No. : 10071738 Age / Sex : 28 Y 0 M 0 D /Male
Referred By : Dr. SURJEET KUMAR CentreCode : TPC DRR
Pat. Address : Sample Recieved : 23/Apr/2020 03:49PM
Approval Date : 23/Apr/2020 04:49PM Sample Collection : 23/Apr/2020 03:49PM
Department of HAEMATOLOGY
Test Result Units Biological Reference Interval
CBC WITH ESR
Haemoglobin 4.1 g/dl 13.6-16.9
TLC (Total Leucocyte Count) 4,300 Cells/µL 4000-10000
Differential Leucocyte Count
Neutrophil 52 undefined 40-80 %
Lymphocyte 45 % 20-40
Monocytes 2 % 2-10
Eosinophils 1 % 1-6
Basophils 0.00 % 0-1
Red Blood Cell Count 0.97 10^6/µL 4.5-5.5
HCT 12.7 % 40-50
MCV 130.9 fL 83-101
MCH 42.3 pg 27-32
MCHC 32.3 g/dL 31.5-34.5
Platelet Count 0.80 Lakh/cumm 1.50-4.10
RDW-CV 18.6 % 11.5-14.5
RDW-SD 77.5 fl 39.0-56.0
ESR (WESTERGREN) 86 mm/hr 0-10
Test has been performed on XP100
Sample Type- Whole Blood
Analyzer- F u l l y a u t o m a t e d a n a l y z e r - , S y s m e x X P - 1 0 0 Reference Book-Dacie and Lewis practical Hematology, 11th edition
Remarks- Test results should be interpreted in correlation with the clinical picture of the patient.
Limitations- False low Platelets count migh be obtained if, sample is kept for long on Room Temperature & Incorrect Sample
collection Volume in EDTA test tube can give erratic test results.
*** End of Report ***
Disclaimer: This report is not for medico-legal purposes. Please consult your physician to correlate clinically.
Sample Collected On : 23/Apr/2020 03:49PM Page 6 of 9
Authenticated On : 23/Apr/2020 04:40PM
NABL ACCREDITED & ISO 9001:2015 CERTIFIED LABORATORY
Sample Collected On : 23/Apr/2020 03:49PM Page 7 of 9
Authenticated On : 23/Apr/2020 04:40PM
LIVER FUNCTION TEST (LFT) WITH GGT
Bilirubin, Total 2.06 mg/dL 0.3-1.1
Bilirubin, Direct 0.58 mg/dL 0.0-0.40
Bilirubin, Indirect 1.48 mg/dL 0.0 - 0.80
SGOT (AST), Serum 111.10 U/L 0- 35
SGPT (ALT), Serum 78.60 U/L 0-45
Alkaline Phosphatase (ALP), Serum 79.0 U/L 54-128
Protein, Total 6.25 g/dL 6.5-8.3
Albumin 4.34 g/dL 3.5-5.2
Globulin 1.91 g/dL 2.30-3.50
Albumin Globlin Ratio 2.27
Gamma Glutamyl Transferase (GGT) 14 u/l 5-85
Test has been performed on EM360
Sample Type: S e r u m / P l a s m a
A n a l y z e r: Fully Automated Biochemistry Analyzer ERBA EM-360 Reference Book for Normal Ranges: Tietz Book of Clinical
Sample Collected On : 23/Apr/2020 03:49PM Page 8 of 9
Authenticated On : 23/Apr/2020 04:40PM
NAME : Mr. SIDDHARTHA Lab No. : 00012004230002
Barcode No. : 10071738 Age / Sex : 28 Y 0 M 0 D /Male
Referred By : Dr. SURJEET KUMAR CentreCode : TPC DRR
Pat. Address : Sample Recieved : 23/Apr/2020 03:49PM
Approval Date : 23/Apr/2020 04:40PM Sample Collection : 23/Apr/2020 03:49PM
Department of BIOCHEMISTRY
Test Result Units Biological Reference Interval
KIDNEY FUNCTION TEST (KFT)
Urea 19.50 mg/dL 19-45
Creatinine 1.85 mg/dL 0.7-1.3
Uric Acid, Serum 8.70 mg/dL 3.7-7.7
Sodium 137.7 mEq/L 137-143
Potassium 3.81 mEq/L 3.80-4.90
Chloride 97.0 mEq/L 94 - 110
Protein, Total 6.25 g/dL 6.5-8.3
Calcium, Serum 9.10 mg/dL 9.1-10.4
Test has been performed on EM360
Sample Type: S e r u m
Methodology : Blood Urea: Enzymatic-Talke & Schubert, Serum creatinine: Enzymatic, Uric Acid: trinder Reaction, Calcium:
Arsenzo III, Sodium: Ion-Selective Electrode (ISE ), Potassium: Ion-Selective Electrode (ISE ), Chloride: Ion-Selective Electrode (ISE )
A n a l y z e r : Fully Automated Biochemistry Analyzer ERBA- EM 360 Reference Ranges from Book Tietz Book of Clinical
Chemistry and Molecular Diagnostics by Nader Rifai, Andrea Rita Horvath & Carl T.Wittwer, Sixth Edition. a n d Reagent kit
insert Erba Mannheim.
Remarks: Please Correlate Results Clinically.
*** End of Report ***
Disclaimer: This report is not for medico-legal purposes. Please consult your physician to correlate clinically.
NABL ACCREDITED & ISO 9001:2015 CERTIFIED LABORATORY
Sample Collected On : 23/Apr/2020 03:49PM Page 9 of 9
Authenticated On : 23/Apr/2020 04:40PM
